This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,500,000
Using novel transplantation strategies and HLA-edited hypoimmunogenic hPSCs to develop a superior islet-like product for T1D treatment
CIHR · 2020 · Principal investigator
Using novel transplantation strategies and HLA-edited hypoimmunogenic hPSCs to develop a superior islet-like product for T1D treatment
Principal investigators: Nostro, Maria Cristina; Drucker, Daniel J; Korbutt, Gregory S; Pepper, Andrew R; Vasconcelos, Sara N
Keywords: Beta Cells; Directed Differentiation; Hla-Editing; Human Pluripotent Stem Cells; Humanized Mice; Regenerative Medicine; Transplantation; Type 1 Diabetes
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.